Search Results 251-260 of 13445 for Birth Control Palette

1. A Study to Evaluate T-DM1 With or Without Abemaciclib in Women and Men with HER2-positive Advanced or Metastatic Breast Cancer - Mayo Clinic

   ... contraceptives, implantable hormonal contraceptives or double barrier method (diaphragm plus condom). Birth control must be used during the treatment period ...

2. Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery - Mayo Clinic

   Participant agrees to use acceptable form of contraception during the study and for up to 7 months after last study drug dose ... pills (i.e. "Mini-pill"); Tubal ...

3. Mayo Clinic

   The stump of a newborn's umbilical cord is usually yellowish green at birth. As the stump dries out and eventually falls off — usually within two weeks ...

4. Biomechanical Analysis of the Carotid Artery Wall in the Healthy Adult Population - Mayo Clinic

   ... population. Once validated, the long-term objective would be to use the measurements as control set for future studies. Participation eligibility.

5. Mayo Clinic

   Before birth, the mother's hormones pass through the baby's system. This can lead to swollen breasts at birth — for both boys and girls. Newborn girls might ...

6. A Study of APG-2575 Alone or in Combination with Other Therapeutic Agents to Treat Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) - Mayo Clinic

   ... birth control with partner(s) throughout the study and for 90 days after ... If hormonal contraceptives are used, the specific contraceptive must have ...

7. Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer - Mayo Clinic

   If sexually active in a way that could lead to pregnancy, must consistently use 2 highly effective methods of birth control, starting at the time of ...

8. A Study to Assess Effectiveness and Safety of SER‑287 in Adults With Active Mild-to-Moderate Ulcerative Colitis - Mayo Clinic

   ... birth control, including the barrier method, oral or parenteral contraceptives, a vasectomized partner or abstinence from sexual intercourse. The ...

9. DAYBREAK: Phase 2 Study in Patients With Specific Gene Defects in the MC4R Pathway - Mayo Clinic

   ... Control and Prevention criteria. Study ... contraception throughout the study and for 90 days following the study. ... contraception during the study.

10. Venetoclax In Combination With ASTX727 For The Treatment Of Chronic Myelomonocytic Leukemia And Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm - Mayo Clinic

    Women of child-bearing potential must agree to use adequate contraception (hormonal birth control or abstinence) prior to study entry and for the duration